Exploring Demographic, Prognostic, and Socioeconomic Determinants of Survival in Lymphocyte-rich Classical Hodgkin Lymphoma: A National Cancer Database Study

This large-scale analysis confirms that age, sex, comorbidities, stage, and treatment type are key determinants of survival in LR-cHL. Insurance status emerged as a significant socioeconomic factor, with Medicaid coverage linked to worse outcomes and uninsured status unexpectedly associated with better survival, warranting further study. These findings highlight the importance of equitable access to standard therapies and suggest areas for future research into healthcare disparities in LR-cHL.